US FDA lifts hold on Seattle Genetics' blood cancer ADC candidate
The US FDA has cleared Seattle Genetics to restart trials of its blood cancer candidate vadastuximab talirine that were halted last year after patient deaths.
Archives for March 7, 2017
UK High Court rules against AbbVie in Humira indication patent battle
Biosimilar developers have welcomed a court ruling against AbbVie regarding Humira indication patents, but an IP lawyer warns the judgement is not binding outside the UK.
Vaxess granted $6m to develop sustained release vaccine patches
Two Bill & Melinda Gates Foundation grants will be used to develop a polio and measles rubella vaccine delivered through microneedles on a sustained-dermal patch.
Kite public offering looks to raise $350m for CAR T cell therapy support
Kite Pharma has announced a public offering to support commercialisation of its lead CAR-based therapy, axicabtagene ciloleucel.
Biodefense: Canada develops novel live virus smallpox vaccine from horsepox
Canada-based Tonix Pharmaceuticals has developed a novel live-virus vaccine for smallpox, which the firm claims is a safer alternative for biodefense stockpiles.